The RNA recognition motif 1 (RRM1) domain of TDP-43 has shown to be a druggable site, with a small molecule able to reduce RNA binding and improve neuromuscular strength in an ALS drosophila model [172]. Here, TARDBP is linked to amyotrophic lateral sclerosis.